https://medical-data-models.org/8757
Bladder Cancer NCT00014534 Follow-Up - CALGB: 90104 Survival Data Form - 2169468v3.0 - Portal of...
CALGB: 90104 Survival Data Form Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder:...
bladder cancerfollow upcalgbsurvivaldata
https://www.clinicalbiostats.com/clinical-trial-results/calgb-40603/
CALGB 40603: Complete Statistical Analysis of Paclitaxel With or Without Carboplatin and...
Independent statistical analysis of CALGB 40603 (NCT00861705), a randomized phase 2 factorial trial evaluating carboplatin and bevacizumab added to neoadjuvant...
statistical analysiscalgbcompletepaclitaxelwithout